Resistance in the anti-angiogenic era: nay-saying or a word of caution?

Author： Sweeney C.J.   Miller K.D.   Sledge G.W.  

Publisher： Elsevier

ISSN： 1471-4914

Source： Trends in Molecular Medicine, Vol.9, Iss.1, 2003-01, pp. : 24-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Angiogenic Cancer Therapy Updates

By  

Current Molecular Medicine, Vol. 9, Iss. 8, 2009-11 ,pp. : 954-966

Bentham Science Publishers

Access to resources Recommend Favorite

Promises and pitfalls of anti-angiogenic therapy in clinical trials

By McCarty M.F.   Liu W.   Fan F.   Parikh A.   Reimuth N.   Stoeltzing O.   Ellis L.M.  

Trends in Molecular Medicine, Vol. 9, Iss. 2, 2003-02 ,pp. : 53-58

Elsevier

Access to resources Recommend Favorite

Angiogenesis and Anti-angiogenic Therapies in Epithelial Ovarian Cancer

By  

Current Angiogenesis, Vol. 3, Iss. 2, 2014-07 ,pp. : 60-65

Bentham Science Publishers

Access to resources Recommend Favorite

PEDF: anti-angiogenic guardian of ocular function

By Bouck N.  

Trends in Molecular Medicine, Vol. 8, Iss. 7, 2002-07 ,pp. : 330-334

Elsevier

Access to resources Recommend Favorite

Targeting Endothelial Progenitor Cells in Cancer as a Novel Biomarker and Anti-Angiogenic Therapy

By  

Current Stem Cell Research & Therapy, Vol. 10, Iss. 2, 2015-03 ,pp. : 181-187

Bentham Science Publishers

Access to resources Recommend Favorite